Please login to order a test.
Hepatitis C Virus (HCV) FibroSure®
Assessment of liver status following a diagnosis of HCV. Baseline determination of liver status before initiating HCV therapy. Posttreatment assessment of liver status six months after completion of therapy. Noninvasive assessment of liver status in patients who are at increased risk of complications from a liver biopsy.
This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary.
Fibrosis Stage (FibroTest)
F2−Bridging fibrosis with few septa
F3−Bridging fibrosis with many septa
Activity Stage (ActiTest)
Separate serum from cells within two hours of collection.
Specimen can be stored refrigerated at 2°C to 8°C for 72 hours and frozen at -70°C for seven days. Frozen samples are stable for one freeze/thaw cycle.
Causes for Rejection
Gross hemolysis; gross lipemia; improper labeling; nonfasting specimen; patient younger than 14 years of age
The patient's age and gender must be included on the test request form.